Aptus Pharma Limited (APPL) Share Price Near 52-Week High on Strong Trading Session
- September 17, 2026
- Posted by: Chaitanya Auti
- Category: News
Aptus Pharma Share Price is Rs 482.10, up 2.00% from the previous close, and it is trading close to its 52-week high with a market capitalisation of Rs 826.8 crore as of 21 October 2026 at 9:22 AM IST. Aptus Pharma Share Price Today places APPL in focus because the latest Univest data confirms a near-peak price event, while the current reading also keeps the company’s valuation metrics in view. Aptus Pharma Share Price is therefore drawing attention in the Indian stock market as a stock news event, but the latest Univest figures do not establish a company-specific catalyst. What is clear is the price print, the near yearly high setup and the fact that Aptus Pharma Share Price Today sits at a level that encourages a closer reading of fundamentals.
Aptus Pharma Share Price moved to Rs 482.10 from a previous close of Rs 472.65, a gain of Rs 9.45 for the ongoing session. The day open, day high and day low were all Rs 482.10, which means the stock is trading at the same level it opened and at the session’s range point so far. For readers tracking Aptus Pharma Share Price Today, this is a clean price event rather than a narrative with an identified trigger. Aptus Pharma Stock News therefore centres on the near 52-week high and the numerical context around the move. The share price also keeps APPL in the list of stocks in news and 52 week high stocks on the Indian stock market.
Aptus Pharma Share Price Today: Price Action Analysis
What matters next is how Aptus Pharma Share Price fits with its valuation and sector context. The stock’s P/E ratio of 178.97, P/B ratio of 24.58, ROE of 30.48%, ROCE of 30.01%, EPS of 2.69, book value of Rs 19.61 and dividend yield of 0 are all part of the current Aptus Pharma Share Price discussion. Those figures are best read alongside the company’s market capitalisation and the benchmark picture for the trading sector. Aptus Pharma Share Price Today is therefore relevant not only because it is near a 52-week high, but also because the financial ratios are far from the industry median in several cases. Univest data keeps the focus on verified numbers, not on a guessed reason for the move.
| Metric | Value |
|---|---|
| Current Price | Rs 482.1 |
| Previous Close | Rs 472.65 |
| Today's Move | +Rs 9.45 (+2%) |
| Open | Rs 482.1 |
| High | Rs 482.1 |
| Low | Rs 482.1 |
| Market Capitalisation | Rs 826.8 crore |
Aptus Pharma Limited (APPL) traded at Rs 482.1 versus the previous close of Rs 472.65, a rise of 2%. The stock opened at Rs 482.1, reached a high of Rs 482.1 and touched a low of Rs 482.1.
Aptus Pharma Share Price Today stands at Rs 482.10 versus the previous close of Rs 472.65, reflecting a day change of Rs 9.45 or 2.00%. The stock opened at Rs 482.10 and also printed a day high and day low of Rs 482.10, so the current reading matches the full intraday range captured so far. Aptus Pharma Share Price is also close to its 52-week high, which is why this session is being tracked as a one-year high style event in market news coverage. For APPL, the useful question is not whether a cause can be assumed; it is whether the price print remains near the yearly high while the session develops. Aptus Pharma Share Price therefore remains a live market update rather than a finished-day story.
For investors scanning Aptus Pharma Share Price, the key point is that the move is measurable and verified, while the reason is not established. Aptus Pharma Share Price News is best read as a price event with a clear gap to the prior close and a nearby 52-week peak. That keeps Aptus Pharma Share Price Today relevant for Indian stock market screens, especially when traders and long-term readers search for Aptus Pharma Share Price Live, APPL stock news and Aptus Pharma Share Price Update on Univest.
Aptus Pharma Limited (APPL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 826.8 crore |
| P/E Ratio | 178.97x |
| P/B Ratio | 24.58x |
| ROE | 30.48% |
| ROCE | 30.01% |
| EPS | Rs 2.69 |
| Book Value Per Share | Rs 19.61 |
| Dividend Yield | 0% |
Aptus Pharma Limited (APPL) fundamental metrics show P/E 178.97x, P/B 24.58x, ROE 30.48%, ROCE 30.01%. These figures provide context only and are not a buy or sell signal.
Aptus Pharma Limited has a market capitalisation of Rs 826.8 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 178.97x, P/B at 24.58x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 30.48% and ROCE of 30.01%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.69, book value per share of Rs 19.61, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 13.13x, median ROE of 4.09%, median ROCE of 5.96%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 178.97x |
| Benchmark Median P/E | 13.13x |
| Benchmark Average P/E | 65.54x |
| Benchmark P/E Range | 0x to 3,170.85x |
| Company P/B Ratio | 24.58x |
| Benchmark Median P/B | 1.31x |
| Company ROE | 30.48% |
| Benchmark Median ROE | 4.09% |
| Company ROCE | 30.01% |
| Benchmark Median ROCE | 5.96% |
| Company Market Capitalisation | Rs 826.8 crore |
| Benchmark Median Market Cap | Rs 53.15 crore |
Aptus Pharma Limited (APPL) is classified under sector: Trading and industry: Trading.
Aptus Pharma Limited (APPL) has a P/E ratio of 178.97x, which is above the benchmark median of 13.13x, a difference of +1,263.06%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aptus Pharma Limited (APPL) has a ROE of 30.48%, which is above the benchmark median of 4.09%, a difference of +645.23%. Aptus Pharma Limited (APPL) has a ROCE of 30.01%, which is above the benchmark median of 5.96%, a difference of +403.52%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Maxgrow India Ltd. | MAXGROW | 828.86 | 1.84 | 0.54 | 2.03 | 1.69 |
| Vision Infra Equipment Solutions Ltd. | VIESL | 801.21 | 12.14 | 3.41 | 33.53 | 22.62 |
| Hexa Tradex Ltd. | HEXATRADEX | 878.11 | 0 | 0.19 | -0.19 | -0.12 |
| The Yamuna Syndicate Ltd. | YSL | 774.86 | 8.49 | 0.6 | 4.07 | 4.15 |
| Vasa Denticity Ltd. | DENTALKART | 763.12 | 65.75 | 4.37 | 6.83 | 8.74 |
Aptus Pharma Limited (APPL) has a P/E ratio of 178.97x compared with the displayed peer median of 8.49x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 30.48% compares with a peer median of 4.07% across the companies shown in the table. ROCE stood at 30.01% versus the displayed peer median of 4.15%, providing a capital-efficiency comparison. Aptus Pharma Limited (APPL) has a market capitalisation of Rs 826.8 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Aptus Pharma
- Aptus Pharma Share Price is Rs 482.10 and is trading near its 52-week high.
- Aptus Pharma Share Price Today is up Rs 9.45, or 2.00%, from the previous close.
- The company’s market cap stands at Rs 826.8 crore.
- P/E of 178.97 and P/B of 24.58 place Aptus Pharma Share Price above the trading sector median.
- ROE of 30.48% and ROCE of 30.01% are above the same-industry median readings.
About Aptus Pharma
Aptus Pharma Limited operates in the trading sector and trading industry. Aptus Pharma Share Price is therefore being tracked within a broad same-industry comparison set rather than an isolated company story. The available classification identifies APPL as a trading-name stock in the listed Indian market. For readers following Aptus Pharma Stock News, the main company context available here is the sector and industry placement, together with the numerical market and valuation readings that currently define Aptus Pharma Share Price.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What is Aptus Pharma Share Price today?
Ans. Aptus Pharma Share Price is Rs 482.10, and it is trading near its 52-week high. The current reading is up Rs 9.45, or 2.00%, from the previous close of Rs 472.65.
Why is Aptus Pharma Share Price in focus today?
Ans. Aptus Pharma Share Price is in focus because it is near its 52-week high and the market capitalisation stands at Rs 826.8 crore. The latest Univest figures confirm the price event without assigning a catalyst.
What was the previous close for Aptus Pharma?
Ans. The previous close for Aptus Pharma Share Price was Rs 472.65. The current price of Rs 482.10 is Rs 9.45 higher, which keeps the stock on market screens for Aptus Pharma Share Price Today.
What is the market cap of Aptus Pharma?
Ans. Aptus Pharma Share Price is being tracked with a market capitalisation of Rs 826.8 crore. That size matters for context, but the near 52-week high event is what is drawing current attention.
How does Aptus Pharma compare on valuation?
Ans. Aptus Pharma Share Price carries a P/E of 178.97 and a P/B of 24.58. Both are above the trading sector median, which stands at 13.13 for P/E and 1.31 for P/B.
What do ROE and ROCE show for Aptus Pharma?
Ans. Aptus Pharma Share Price comes with ROE of 30.48% and ROCE of 30.01%. Both readings are well above the same-industry medians, which provides important context for Aptus Pharma Stock News.
What is the EPS and book value for Aptus Pharma?
Ans. Aptus Pharma Share Price can be read alongside EPS of 2.69 and book value of Rs 19.61. These figures help frame earnings per share and accounting net worth for APPL.
Does Aptus Pharma pay a dividend?
Ans. Aptus Pharma Share Price is paired with a dividend yield of 0. That means the current analysis is focused on price, valuation and return metrics rather than payout yield.
Track Aptus Pharma Share Price on Univest
Use Aptus Pharma Limited (APPL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Aptus Pharma Share Price on Univest to follow live price updates, key financial ratios, market capitalisation, sector context and 52-week levels in one place. Univest also helps readers review Aptus Pharma Share Price Today alongside earnings-related metrics and stock news coverage.